While our findings suggest that serum progranulin levels may be a useful biomarker for physical frailty independent of sarcopenia, further studies are needed to validate these associations and assess the utility of serum progranulin levels as a potential biomarker for frailty. This evidence concerns the gene GRN and sarcopenia.